While reporting financial results for the first quarter on Tuesday, pet healthcare provider IDEXX Laboratories, Inc. (IDXX) raised its earnings and revenue guidance for the full-year 2026.
For fiscal 2026, the company now projects earnings in a range of $14.45 to $14.90 per share on revenues between $4.675 billion and $4.760 billion, with revenue growth of 8.6 to 10.6 percent and organic revenue growth of 7.7 to 9.7 percent.
Previously, the company expected earnings in the range of $14.29 to $14.80 per share on revenues between $4.632 billion and $4.720 billion, with revenue growth of 7.6 to 9.6 percent and organic revenue growth of 7 to 9 percent.
In Tuesday's pre-market trading, IDXX is trading on the Nasdaq at $564.99, up $1.87 or 0.33 percent.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
For comments and feedback contact: editorial@rttnews.com
Business News
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.